| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2'-5'-oligoadenylate synthetase 1 | 0.626 | 0.654 | 3.4E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
5'-nucleotidase ecto | 0.436 | 0.885 | 2.3E-11 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
5'-nucleotidase, cytosolic IA | 0.615 | 0.654 | 8.3E-05 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2010 | 2019 | ||||||||
|
5-azacytidine induced 2 | 0.760 | 0.577 | 6.9E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
7-dehydrocholesterol reductase | 0.500 | 0.846 | 3.9E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
abhydrolase domain containing 6 | 0.751 | 0.385 | 2.2E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
absent in melanoma 2 | 0.521 | 0.769 | 2.2E-09 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2020 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
achaete-scute family bHLH transcription factor 2 | 0.691 | 0.423 | 0.35 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2012 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
acidic nuclear phosphoprotein 32 family member B | 0.541 | 0.731 | 0.96 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2019 | ||||||||
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2019 | ||||||||
|
activated leukocyte cell adhesion molecule | 0.502 | 0.808 | 0.73 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
activating transcription factor 7 interacting protein | 0.543 | 0.769 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2015 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.380 | None | 1.000 | 9 | 0 | 2006 | 2018 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2014 | ||||||||
|
acyl-CoA dehydrogenase family member 8 | 0.506 | 0.885 | 5.6E-14 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 2005 | 2019 | ||||||||
|
acyl-CoA synthetase bubblegum family member 1 | 0.603 | 0.654 | 4.0E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 |